Zakharenko , A. A., Vovin , K. N., Zolotukhina , A. E., Belyaev , M. A., Khamid , A. K., & Svechkova , A. A. (2024). Surgical Methods in Treatment of Metastatic Gastric Cancer. Literature Review. Voprosy Onkologii, 70(5), 826–834. https://doi.org/10.37469/0507-3758-2024-70-5-826-834

Abstract

regimens and the modernization of surgical techniques (implementation of liver-directed therapy, conversion surgery, HIPEC and PIPAC with cytoreductive surgery), the prognosis for these patients remains poor. The most common sites of distant metastases in gastric cancer are liver, peritoneum and para-aortic lymph nodes. This article summarizes the results of an analysis of publications in recent years on surgical management of metastatic gastric cancer and highlights possible treatment options for different clinical cases. The following conclusions were drawn from this study: not all cases of metastatic gastric cancer are indications for palliative chemotherapy and supportive symptomatic therapy alone. The most optimal and effective treatment is a personalized approach to each patient. Whenever possible, combination therapy, including systemic and local treatment, should be chosen.

https://doi.org/10.37469/0507-3758-2024-70-5-826-834

##article.numberofdownloads## 94

##article.numberofviews## 204

pdf (Русский)

References

Stomach. The Global Cancer Observatory. December, 2020. International Agency for Research on Cancer (IARC). 1965-2024.-URL: https://gco.iarc.fr/today/data/factsheets/cancers/7-Stomach-fact-sheet.pdf

Куваев Р.О., Кашин C.В., Никонов Е.Л., et al. Ранний рак желудка: современные методики скрининга, эндоскопической диагностики и малоинвазивного лечения. Доказательная гастроэнтерология. 2014; 3(3): 44‑51. [Kuvaev R.O., Kashin S.V., Nikonov E.L., et al. Early stomach cancer: the modern methods for screening, endoscopic diagnostics, and minimally invasive treatment. Russian Journal of Evidence-Based Gastroenterology. 2014; 3(3): 44‑51. (In Rus)].

Zhang K., Chen L. Chinese consensus on the diagnosis and treatment of gastric cancer with liver metastases. Ther Adv Med Oncol. 2020; 12: 1758835920904803.-DOI: https://doi.org/10.1177/1758835920904803.

Ajani J.A., D'Amico T.A., Bentrem D.J., et al. Gastric Cancer, Version 2.2022, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2022; 20(2): 167-192.-DOI: https://doi.org/10.6004/jnccn.2022.0008.

Luo Z., Rong Z., Huang C. Surgery strategies for gastric cancer with liver metastasis. Front Oncol. 2019; 9: 1353.-DOI: https://doi.org/10.3389/fonc.2019.01353.

Guner A., Vildirim R. Surgical management of metastatic gastric cancer: moving beyond the guidelines. Transl Gastroenterol Hepatol. 2019; 4: 58.-DOI: https://doi.org/10.21037/tgh.2019.08.03.

Aurello P., Minervini A., Pace M., et al. The role of surgery in the treatment of metachronous liver metastasis from gastric cancer: a systematic review. Anticancer Res. 2022; 42(1): 25-33.-DOI: https://doi.org/10.21873/anticanres.15453.

Sun M., Ding H., Zhu Z., et al. Identifying optimal surgical intervention-based chemotherapy for gastric cancer patients with liver metastases. Front Oncol. 2021; 11: 675870.-DOI: https://doi.org/10.3389/fonc.2021.675870.

Fan X., Zhang Y., Zhang M., et al. Ultrasound-guided secondary radiofrequency ablation combined with chemotherapy in gastric cancer with recurrent liver metastasis. Transl Cancer Res. 2020; 9(4): 2349-2356.-DOI: https://doi.org/10.21037/tcr.2020.03.45.

Lentz R.W., Messersmith W.A. Transarterial radioembolization in patients with unresectable colorectal cancer liver metastases. J Clin Oncol. 2021; 39(35): 3887-3889.-DOI: https://doi.org/10.1200/JCO.21.01993.

Wang K., Zhang X., Wei J., et al. Hepatic arterial infusion oxaliplatin plus oral S-1 chemotherapy in gastric cancer with unresectable liver metastases: a case series and literature review. Cancer Manag Res. 2020; 12: 863-870.-DOI: https://doi.org/10.2147/CMAR.S233123.

Qiang W., Shi H., Wu J., et al. Hepatic arterial infusion combined with systemic chemotherapy for patients with extensive liver metastases from gastric cancer. Cancer Manag Res. 2020; 12: 2911-2916.-DOI: https://doi.org/10.2147/CMAR.S245697.

Akamaru Y., Wada N., Adachi S., et al. [Two Cases of Liver Metastasis from Gastric Cancer Achieving Long-Term Survival Successfully Treated with Stereotactic Body Radiotherapy(SBRT) (In Japanese)]. Gan To Kagaku Ryoho. 2019; 46(13): 2110-2112.

Rau B., Brandl A., Thuss-Patience P., et al. The efficacy of treatment options for patients with gastric cancer and peritoneal metastasis. Gastric Cancer. 2019; 22(6): 1226-1237.-DOI: https://doi.org/10.1007/s10120-019-00969-1.

Rau B., Brandl A., Piso P., et al. Peritoneal metastasis in gastric cancer: results from the German database. Gastric Cancer. 2020; 23(1): 11-22.-DOI: https://doi.org/10.1007/s10120-019-00978-0.

Gwee Y.X., Chia D.K.A., So J., et al. Integration of genomic biology into therapeutic strategies of gastric cancer peritoneal metastasis. J Clin Oncol. 2022; 40(24): 2830.-DOI: https://doi.org/10.1200/JCO.21.02745.

Gronau F., Feldbruegge L., Oberwittler F., et al. HIPEC in peritoneal metastasis of gastric origin: a systematic review of regimens and techniques. J Clin Med. 2022; 11(5): 1456.-DOI: https://doi.org/10.3390/jcm11051456.

Bonnot P.E., Piessen G., Kepenekian V., et al. Cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy for gastric cancer with peritoneal metastases (CYTO-CHIP study): a propensity score analysis. J Clin Oncol. 2019; 37(23): 2028-2040.-DOI: https://doi.org/10.1200/JCO.18.01688.

Russo A.E., Strong V.E. Gastric cancer etiology and management in Asia and the West. Annu Rev Med. 2019; 70: 353-367.-DOI: https://doi.org/10.1146/annurev-med-081117-043436.

Badgwell B.D. Don't call it a comeback-HIPEC for gastric cancer. Ann Surg Oncol. 2022; 29(12): 7244-7245.-DOI: https://doi.org/10.1245/s10434-022-12383-6.

Alyami M., Hubner M., Grass F., et al. Pressurised intraperitoneal aerosol chemotherapy: rationale, evidence, and potential indications. Lancet Oncol. 2019; 20(7): e368-77.-DOI: https://doi.org/10.1016/S1470-2045(19)30318-3.

Javanbakht M., Mashayekhi A., Branagan-Harris M., et al. Cost-effectiveness analysis of pressurized intraperitoneal aerosol chemotherapy (PIPAC) in patients with gastric cancer and peritoneal metastasis. Eur J Surg Oncol. 2022; 48(1): 188-196.-DOI: https://doi.org/10.1016/j.ejso.2021.08.024.

Lu S., Chen Y.G., Liu X.W., et al. A phase II study of perioperative treatment in gastric cancer with No.16a2/b1 lymph node metastasis: DRAGON-06 trial. Future Oncol. 2022; 18(39): 4239-4349.-DOI: https://doi.org/10.2217/fon-2022-0718.

Zheng X.H., Zhang W., Yang L., et al. Role of D2 gastrectomy in gastric cancer with clinical para-aortic lymph node metastasis. World J Gastroenterol. 2019; 25(19): 2338-2353.-DOI: https://doi.org/10.3748/wjg. v25.i19.2338.

Qiu M.Z., Shi S.M., Chen Z.H., et al. Frequency and clinicopathological features of metastasis to liver, lung, bone, and brain from gastric cancer: A SEER-based study. Cancer Med. 2018; 7(8): 3662-3672.-DOI: https://doi.org/10.1002/cam4.1661.

Захаренко А.А., Беляев М.А., Вервекин И.В., Палтышев И.А. Методы профилактической внутрибрюшинной химиотерапии в лечении рака желудка с высокими рисками перитонеального канцероматоза (обзор литературы). Вопросы онкологии. 2023; 69(2): 195-202.-DOI: https://doi.org/10.37469/0507-3758- 2023-69-2-195-202. [Zakharenko A.A, Belyaev M.A, Vervekin I.V, Paltyshev I.A. Preventive intraperitoneal chemotherapy in treating gastric cancer with high-risk peritoneal carcinomatosis (literature review). Voprosy Onkologii = Problems in Oncology. 2023; 69(2): 195-202.-DOI: https://doi.org/10.37469/0507-3758-2023-69-2-195-202. (In Rus)].

Zhang Y., Lin Y., Duan J., et al. A population-based analysis of distant metastasis in stage IV gastric cancer. Med Sci Monit. 2020; 26: e923867.-DOI: https://doi.org/10.12659/MSM.923867.

Gligorievski A. Appearance of Krukenberg tumor from gastric carcinoma, ultrasound and computed tomography evaluation. Digestive Medicine Research. 2018; 1: 3-3.-DOI: https://doi.org/10.21037/dmr.2018.06.01.

Ma F., Li Y., Li W., et al. Metastasectomy improves the survival of gastric cancer patients with krukenberg tumors: a retrospective analysis of 182 patients. Cancer Manag Res. 2019; 11: 10573-10580.-DOI: https://doi.org/10.2147/CMAR.S227684.

Lionetti R., De Luca M., Travaglino A., et al. Treatments and overall survival in patients with Krukenberg tumor. Arch Gynecol Obstet. 2019; 300(1): 15-23.-DOI: https://doi.org/10.1007/s00404-019-05167-z.

Wu X.J., Yuan P., Li Z.Y., et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy improves the survival of gastric cancer patients with ovarian metastasis and peritoneal dissemination. Tumour Biol. 2013; 34(1): 463-9.-DOI: https://doi.org/10.1007/s13277-012-0571-4.

Хомяков В., Соболев Д., Колобаев И., et al. Конверсионная хирургия при раке желудка IV. Обзор литературы и опыт МНИОИ им. П.А. Герцена. Вопросы онкологии. 2020; 66(1), 50-57.-DOI: https://doi.org/10.37469/0507-3758-2020-66-1-50-57. [Khomiakov V.M., Sobolev D.D., Kolobaev I.V., et al. Conversion surgery for stage IV gastric cancer. Literature review and own experience. Voprosy Onkologii = Problems in Oncology. 2020; 66 (1), 50-57.-DOI: https://doi.org/10.37469/0507-3758-2020-66-1-50-57. (In Rus)].

Rau B., Lang H., Koenigsrainer A., et al. Effect of hyperthermic intraperitoneal chemotherapy on cytoreductive surgery in gastric cancer with synchronous peritoneal metastases: the phase III GASTRIPEC-I trial. J Clin Oncol. 2023.-DOI: https://doi.org/10.1200/JCO.22.02867.

Rau B., Feldbrügge L., Gronau F., et al. Indication of hyperthermic intraperitoneal chemotherapy in gastric cancer (Gastripec, Gastrichip). Visc Med. 2022; 38(2): 81-89.-DOI: https://doi.org/10.1159/000522604.

Ryu T., Takami Y., Wada Y., et al. Oncological outcomes after hepatic resection and/or surgical microwave ablation for liver metastasis from gastric cancer. Asian J Surg. 2019; 42(1): 100-105.-DOI: https://doi.org/10.1016/j.asjsur.2017.09.005.

Захаренко А.А., Беляев М.А., Трушин А.А., et al. Первые результаты применения лапароскопической аэрозольной внутрибрюшинной химиотерапии (PIPAC) при лечении карциноматоза брюшины у больных раком желудка. Вопросы онкологии. 2018; 64(2): 222-227.-DOI: https://doi.org/10.37469/0507-3758-2018-64-2-222-227. [Zakharenko A.A, Belyaev M.A, Trushin A.A., et al First results of laparoscopic pressurized intraperitoneal aerosol chemotherapy (PIPAC) in treatment for peritoneal carcinomatosis in patients with gastric cancer. Voprosy Onkologii = Problems in Oncology. 2018; 64(2): 222-227.-DOI: https://doi.org/10.37469/0507-3758-2018-64-2-222-227. (In Rus)].

Захаренко А.А., Беляев М.А., Трушин А.А., et al. Сравнительный анализ эффективности различных методов регионарной внутрибрюшинной химиотерапии. Вопросы онкологии. 2018; 64(2): 266-271.-DOI: https://doi.org/10.37469/0507-3758-2018-64-2-266-271. [Zakharenko A.A, Belyaev M.A, Trushin A.A., et al. Comparative analysis of the efficacy of various methods of regional intraperitoneal chemotherapy. Voprosy Onkologii = Problems in Oncology. 2018; 64 (2): 266-271.-DOI: https://doi.org/10.37469/0507-3758-2018-64-2-266-271. (In Rus)].

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Most read articles by the same author(s)

Aleksandr A. Zakharenko, Mikhail A. Belyaev, Anna A. Svechkova, Ilya Vervekin, Abdo Herreddin Hamid, Илья Александрович Палтышев, Sergey F. Bagnenko, Kirill N. Vovin, Kupenskaya, D2 Gastrectomy in Combination with Simultaneous Pressurized Intraperitoneal Chemotherapy (PIPAC) for Gastric Cancer: Immediate Results of the GASPACCO Clinical Trial Protocol. Safety Analysis , Voprosy onkologii: Vol. 70 No. 5 (2024)